Novartis this week announced the launch of the Greater Manchester (UK) Future of Health Challenge and named the start-up businesses selected to participate. The intensive 12-week program will include training, mentoring, and support from leaders in the health and technology space to create new clinical solutions for patients in Greater Manchester and beyond. Fifteen participants were selected from over 100 applicants who replied to the call for creative use of new technologies to solve some of Greater Manchester’s most pressing health problems. In addition to access to world-class support and expertise, participating start-up companies also have a chance to receive cloud space and additional expert support from Google Cloud for Startups. Developmental projects entering the program range from advanced visualization software and tools to help improve cognition, to home-based care systems that support elderly independent living and a remote thermometer which requires no contact with the patient. The program asked applicant health technology start-ups and entrepreneurs to submit ideas that could be beneficial to one or more of three focus areas as selected by local health leaders: • Solutions that improve the experience of those with Dementia and/or Frailty. • Solutions allowing primary care and outpatient services to be delivered in or near the home for patients. • Innovations to allow Digital Nudges to improve Prevention and Public Health. The program's fifteen participants are:
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.